Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.46 |
| ▸ | SELL | P14151 | 1/20 | 0.45 |
| ▸ | SELP | P16109 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | TPMT | P51580 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6474772 | 0.85 | TDP1 (0.58) | TDP1MAPTCSNK2A1SELLSELP | |
| SCHEMBL10408222 | 0.85 | ALDH1A1 (0.50) | TDP1MAPTHTTALDH1A1HSD17B10 | |
| SCHEMBL419245 | 0.84 | TDP1 (0.56) | TDP1MAPTCSNK2A1SELLSELP | |
| SCHEMBL17644155 | 0.83 | CA12 (0.50) | TDP1MAPTMYCALDH1A1HSD17B10 | |
| SCHEMBL5789827 | 0.83 | NNMT (0.46) | TDP1MAPTALDH1A1HSD17B10TSHR | |
| SCHEMBL11218412 | 0.82 | TDP1 (0.50) | TDP1MAPTHTTMYCALDH1A1 | |
| SCHEMBL12683255 | 0.82 | TDP1 (0.70) | TDP1MAPTCSNK2A1SELLSELP | |
| SCHEMBL2425023 | 0.81 | MAPT (0.68) | TDP1MAPTHTTMYCTPMT | |
| SCHEMBL30466426 | 0.81 | MAPT (0.68) | TDP1MAPTHTTMYCTPMT | |
| SCHEMBL31746160 | 0.81 | TDP1 (0.53) | TDP1MAPTCSNK2A1SELLSELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119504444-A | Preparation method of 5-nitrovanillic acid | 浙江工业大学 | 2025-02-25 | — | — | CN | claimed |
| CN-112334131-B | Pharmaceutical composition comprising indirubin derivative as active ingredient | CK生物技术公司 | 2024-04-05 | — | — | CN | claimed |
| CN-116804657-A | Identification method of various anti-hair loss chemical drugs in cosmetics | 重庆海关技术中心 | 2023-09-26 | — | — | CN | claimed |
| CN-113046179-B | Dendrobium officinale flower fragrance composition and preparation method and application thereof | 中国科学院昆明植物研究所 | 2023-06-06 | — | — | CN | claimed |
| CN-115141334-A | Sulfur-containing bio-based benzoxazine resin and preparation method thereof | 中北大学 | 2022-10-04 | — | — | CN | claimed |
| CN-110093064-B | Preparation method and application of long-afterglow luminescent ink | 重庆理工大学 | 2021-07-13 | — | — | CN | claimed |
| CN-109715220-A | Oil agent and lubricating oil for odor conversion | 山本香料株式会社 | 2019-05-03 | — | — | CN | claimed |
| CN-109689117-A | Foul smell method of converting | 山本香料株式会社 | 2019-04-26 | — | — | CN | claimed |
| CN-106889311-A | Mixed feed prepared by a kind of use shrimping beam trawl | 浙江海洋大学 | 2017-06-27 | — | — | CN | claimed |
| US-20040261198-A1 | Restructuring and finishing of keratin fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-12-30 | — | — | US | claimed |
| CN-121653048-A | Method for inducing and differentiating fibroblast into vascular endothelial cell | 海南博鳌未来医院有限公司 | 2026-03-13 | — | — | CN | disclosed |
| CN-120741684-A | Gout wet syndrome biomarker, diagnosis/prediction model and construction method thereof | 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） | 2025-10-03 | — | — | CN | disclosed |
| US-20250302842-A1 | HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS | Jubilant Epipad LLC | 2025-10-02 | — | — | US | disclosed |
| US-12357639-B2 | Heterocyclic compounds as pad inhibitors | Jubilant Epipad LLC (US) | 2025-07-15 | — | — | US | disclosed |
| CN-120098190-A | Macroporous resin material and preparation method thereof | 北华大学 | 2025-06-06 | — | — | CN | disclosed |
| US-20040261198-A1 | Restructuring and finishing of keratin fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2004-12-30 | — | — | US | disclosed |
| US-6541038-B1 | Impregnating wood with metal-containing treating agent containing lignin and/or lignin derivatives and a metal, a metal compound, and/or a metal ion, and oxidizing and/or macromolecularizing the lignin | SDS BIOTECH K.K. (JP) | 2003-04-01 | — | — | US | disclosed |
| US-20030017565-A1 | COMPOSITION AND METHOD FOR TREATING A POROUS ARTICLE AND USE THEREOF | SDS BIOTECH K.K. (JP) | 2003-01-23 | — | — | US | disclosed |
| EP-1034903-A1 | METHOD FOR THE TREATMENT OF WOOD WITH METALLIC TREATMENT AND WOOD TREATED BY THE METHOD | Showa Denko Kabushiki Kaisha (JP) | 2000-09-13 | — | — | EP | disclosed |
| EP-0953634-A1 | COMPOSITION FOR TREATING POROUS ARTICLE, TREATMENT METHOD, AND USE THEREOF | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1999-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250302842-A1 | HETEROCYCLIC COMPOUNDS USEFUL FOR TREATMENT OF CANCERS | NES, VHL, ETV6 | TDP1 3537/4885MAPT 2514/4885CSNK2A1 1241/4885 |
| US-12357639-B2 | Heterocyclic compounds as pad inhibitors | PADI4, PADI2, PADI1 | TDP1 62/4885MAPT 4416/4885CSNK2A1 1737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.